-
Researchers Develop Biomarker Algorithm for Noninvasive Detection of Barrett's Esophagus and Esophageal Cancer
23 Jan 2025 02:39 GMT
FOR IMMEDIATE RELEASE
By studying biomarkers known to be involved in gastrointestinal cancers, researchers at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a biomarker algorithm that, when …
-
Previse Showcases New Data Highlighting Clinical Utility of Esopredict® Barrett's Esophagus Prognostic Test at ACG 2024
28 Oct 2024 15:49 GMT
Epigenetic test for risk-stratification impacts gastroenterologists' decision making and improves confidence when caring for patients with Barrett's esophagus.
BALTIMORE, Oct. 28, 2024 /PRNewswire/ -- Previse, a gastrointestinal health …
-
First steps towards national screening for Barrett's esophagus
28 Oct 2024 02:12 GMT
Funder: Dr. Aoki is supported by theAPAGE/JGH Foundation Clinician-ScientistTraining Fellowship. Dr. Bulamu is supported bya Cancer Council South Australia Beat CancerEarly Career Research Fellowship
From: Flinders University
New research is exploring …
-
New Assay Predicts Cancer Risk in Barrett's Esophagus
30 Sep 2024 13:33 GMT
TOPLINE:
A new epigenetic assay is able to stratify patients with Barrett's esophagus into lower-risk and higher-risk categories for progression to high-grade dysplasia or esophageal adenocarcinoma within 5 years, aiding in clinical decision-making.
…
-
Barrett's Esophagus: Patient-Centered Tx Approach Is Key
20 May 2024 07:51 GMT
The American Gastroenterological Association (AGA) has released updated evidence-based recommendations on the endoscopic eradication therapy (EET) of Barrett's esophagus (BE) and related neoplasms.
Published in Gastroenterology, the clinical practice …
-
WATS3D® Significantly Boosts Barrett's Esophagus and Dysplasia Detection Rates in Landmark Clinical Study
17 May 2024 00:00 GMT
Pivotal Multi-Center Study Highlights AI Platform's Powerful Diagnostic Impact and Ability to Enhance Patient Outcomes
SUFFERN, N.Y., May 17, 2024 /PRNewswire/ -- CDx Diagnostics, Inc., developer of the WATS3D AI Platform for the detection and …
-
Endoscopic Bile Reflux Strongly Associated with Barrett's Esophagus, finds study
03 May 2024 18:58 GMT
Researchers have found that endoscopic evidence of bile reflux is strongly associated with the presence of Barrett's esophagus. This finding comes from a retrospective analysis of a prospectively maintained database of consecutive patients who …
-
Advancing Precision in Barrett's Esophagus and Dysplasia Diagnoses: WATS3D Study Demonstrates Exceptional Consensus Among Pathologists
07 Mar 2024 09:50 GMT
SUFFERN, N.Y., March 6, 2024 /PRNewswire/ -- CDx Diagnostics, Inc., developer of the WATS3D AI platform for the detection and surveillance of Barrett's esophagus (BE) and dysplasia, today announced the publication of "WATS3D: An …
-
Oral Microbiome Dysbiosis: Biomarker for Upper GI Disorders?
21 Jan 2025 09:13 GMT
TOPLINE:
Dysbiosis of the oral microbiome is associated with various upper gastrointestinal (UGI) disorders and precancerous lesions, with specific microbial signatures varying by disease and oral site, research shows.
METHODOLOGY:
Emerging evidence …
-
Antireflux surgery not better than medical therapy for reducing risk of esophageal adenocarcinoma in Barrett's esophagus
28 Sep 2023 19:21 GMT
In patients with Barrett's esophagus (BE), antireflux surgery controls reflux symptoms and heals reflux-induced esophageal mucosal inflammation. This prevents the progression of BE to adenocarcinoma. The antireflux surgery and ablative endoscopic …
About
© 1995-2025